Covance
Home About Covance Investor Relations News Careers Contact Us
Home > Drug Development Services > Nonclinical > Program Management > News, Events & Publications
 Advanced Search
Take me to...
Find a service
Drug Development Services
Nonclinical
Clinical
Commercialization
Industries We Serve
Biotech
Environmental
Food & Dietary Supplements
Pharma
Research
Vaccines
Antibody Products Store
Volunteer for a Study
Investigators
Information Library
Animal Welfare
Program Management
News, Events & Publications
Publications
Key Factors in the Safety Assessment of High-Risk Medicines
Peter Thomas, PhD and Karen Cornelissen, PhD
Covance Evolutions Newsletter
Volume 12, No. 3, February 2008
Download PDF

Effective Project Management for Multi-sourced Early Drug Development
Philip Teitelbaum, PhD; Peter Sausen, PhD; and Robert Turcan, PhD
Covance Evolutions Newsletter
Volume 11, No. 2, November 2006
Download PDF

A New Development Paradigm — Reprint
Article cites Covance CEO Joe Herring's contention that the industry is now looking at drug development as an operationally driven three-step process consisting of discovery, proof of concept (POC), and confirmation, rather than the traditional regulatory-driven 5-step framework of discovery, preclinical testing, and three phases of clinical research.
Pharmaceutical Technology Magazine
March 2006
Download PDF
Overview
News, Events & Publications
Contact